#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive multifocal leukoencephalopathy Metastatic malignant melanoma Demyelination Arrhythmogenic right ventricular dysplasia Wiskott-Aldrich syndrome Glomerulonephritis rapidly progressive Wolfram syndrome Small cell lung cancer limited stage Scleroderma associated digital ulcer Hepatic cirrhosis Duchenne muscular dystrophy Oesophageal adenocarcinoma Hypoparathyroidism Ischaemic stroke Cutaneous T-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Treatment Alport’s syndrome – Basic Information Stevens-Johnson syndrome – Life with Disease Isodicentric chromosome 15 syndrome – Life with Disease Piriformis syndrome – Diagnostics Systemic sclerosis pulmonary Familial amyotrophic lateral sclerosis Proteus syndrome – Trials in Disease Wolfram syndrome – Treatment Friedreich’s ataxia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lna043 Morf-057 Octreotide Hydrochloride Corifollitropin Alfa Patisiran Certolizumab Pegol Abacavir Vidofludimus Calcium Dersimelagon Phosphate Sildenafil ASP3082 BGB-16673 Dicloxacillin Apalutamide Glipizide Durvalumab Bifikafusp Alfa Haemophilus Influenzae Ltx-315 Cabotegravir More therapies…

    Learn about Your Condition

    Wolfram syndrome Normal pressure hydrocephalus Foetal growth restriction Follicular lymphoma stage IV Hairy cell leukaemia Vulval cancer Endometrial adenocarcinoma Familial hypertriglyceridaemia Muscle injury Vulvovaginal candidiasis Breast cancer female B-cell lymphoma Deafness bilateral Lung cancer metastatic Neurogenic bladder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Schizophrenia

  • Study on Tolcapone for Improving Cognitive Symptoms in Patients with Long-Standing Schizophrenia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Tolcapone
    Spain

  • Study on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Schizophrenia
    Investigated Drugs:
    • (2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
    Bulgaria Czechia Poland

  • Study of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria

  • Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Iclepertin
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study on the Safety and Tolerability of Cariprazine for Treating Schizophrenia in Adolescents Aged 13-17

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Cariprazine Hydrochloride
    • Cariprazine
    Bulgaria Germany Romania

  • Study on the Safety and Effectiveness of Olanzapine for Patients with Schizophrenia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Schizoaffective disorder
    • Schizophrenia
    Investigated Drugs:
    • Olanzapine
    Czechia
Previous Page
1 … 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!